2-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)-3-methylpyridine, 1g

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate, 95.0%, 5g

Cyclopentane-1,1-dicarboxylic acid, 97.0%, 100g

2-Chloro-5-methylisonicotinic acid, 95%, 5g

2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 1g

3-allyl-5-ethoxy-4-propoxybenzaldehyde, 95.0%, 1g

ethyl (2Z)-2-chloro-2-[2-(3,5-dimethylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g

(S)-N-(4-((4,4-DIMETHYLCYCLOHEXYL)OXY)-5-FLUORO-2-METHOXYBENZYL)PYRROLIDINE-2-CARBOXAMIDE, 95.0%, 250mg

DAPI, minimo 98%, per biochimica, 10 mg, confezione in vetro

4-Acetoxybenzoic acid, 98.0%, 500g

2-[(Dimethylamino)methylene]-5-(4-fluorophenyl)-1,3-cyclohexanedione, 98%, 500mg

Allyltriphenylphosphonium bromide, 95.0%, 250g

trans-Styrylacetic acid, 99.0%, 50g